Bullish
Edesa Biotech Schedules Phase 2 Vitiligo Study for Mid-2026
Edesa Biotech plans to begin enrollment for its Phase 2 clinical study of EB06, a potential treatment for nonsegmental vitiligo, in mid-2026. The comp...
EDSA
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest EDSA News
Bullish
Research EDSA on:
Ad Space